BlackRock Investment Management, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 47 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$5,0000.0%4,8370.0%0.00%
Q3 2016$5,000
-28.6%
4,8370.0%0.00%
Q2 2016$7,000
+40.0%
4,837
+39.0%
0.00%
Q1 2016$5,000
-16.7%
3,4790.0%0.00%
Q4 2015$6,000
-14.3%
3,479
+12.4%
0.00%
Q3 2015$7,000
-12.5%
3,0960.0%0.00%
Q2 2015$8,000
-95.6%
3,096
-94.3%
0.00%
Q1 2015$182,000
-2.2%
54,225
+1.0%
0.00%
Q4 2014$186,000
-30.9%
53,695
+0.5%
0.00%
Q3 2014$269,000
-62.4%
53,413
+3.0%
0.00%
-100.0%
Q2 2014$716,00051,8740.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$276,0000.10%
Geneos Wealth Management Inc. 445,200$725,0000.05%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$20,0000.01%
Vivaldi Capital Management LP 19,261$30,0000.01%
Atria Wealth Solutions, Inc. 278,700$454,2810.01%
OSAIC HOLDINGS, INC. 1,302,122$2,123,0000.01%
BARRETT & COMPANY, INC. 4,984$5,6320.00%
Ameritas Advisory Services, LLC 45,302$74,0000.00%
CENTAURUS FINANCIAL, INC. 20,732$34,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 19,255$31,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders